| Name | Title | Contact Details |
|---|
Boise Co-op is a food cooperative founded in 1973 in Boise, Idaho, featuring natural foods from over 180 local and regional food producers.
A family business with core values of work hard, play hard. We are proud to offer Ultra-Premium Co-Packing, Private Label, and Canning Services. Explore our award-winning line of Ultra-Premium beverages and join us in keeping the blue marble blue.
CAROLINA BEVERAGE GROUP We are a world-class specialty beverage co-packer for leading beverage brands Learn More
1440 Foods is a company that provides nutrition and support to help people power through lifes everyday moments and most challenging activities.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.